SCHEMBL19911424

SCHEMBL19911424

N#Cn1cnc2cc(F)ccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.34
▸ GFER P55789 1/20 0.34
▸ PRPS1 P60891 1/20 0.34
▸ HTR3E A5X5Y0 2/20 0.33
▸ HTR3B O95264 2/20 0.33
▸ HTR3A P46098 2/20 0.33
▸ HTR3D Q70Z44 2/20 0.33
▸ HTR3C Q8WXA8 2/20 0.33
▸ LMNA P02545 2/20 0.32
▸ MAPK10 P53779 2/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ USP2 O75604 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ DPP4 P27487 1/20 0.32
▸ TSHR P16473 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ GRM5 P41594 1/20 0.31
▸ QPCT Q16769 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19848118 0.86 DPP4 (0.35) KMT2AGFERDPP4QPCT
SCHEMBL19848212 0.79 GABRP (0.47) KDM4EALDH1A1GRM5QPCTQPCTL
SCHEMBL19911408 0.79 MAPT (0.51) KMT2AHTR3ALMNAKDM4EALDH1A1
SCHEMBL19911326 0.79 FGFR1 (0.50) KMT2AKDM4EALDH1A1MAPTHSD17B10
SCHEMBL19915928 0.78 PKM (0.44) KMT2AHTR3EHTR3BHTR3AHTR3D
SCHEMBL19848701 0.75 PRPS1 (0.42) KMT2APRPS1KDM4EALDH1A1USP2
SCHEMBL626716 0.73 TDP1 (0.48) KMT2ALMNAHSD17B10
SCHEMBL19848508 0.72 GFER (0.36) KMT2AGFERPRPS1LMNAMAPK10
SCHEMBL6761540 0.72 GRM5 (0.51) KMT2AGFERPRPS1LMNAKDM4E
SCHEMBL19848447 0.70 POLB (0.46) KMT2AGFERLMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10756394-B2 Nonaqueous electrolyte and nonaqueous secondary battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2020-08-25 — — US disclosed
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-03-01 — — US disclosed
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-03-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10756394-B2 Nonaqueous electrolyte and nonaqueous secondary battery BPTF, BRD4, KCNN2 KMT2A 458/4885GFER 3037/4885PRPS1 3878/4885
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery BPTF, BRD4, KCNN2 KMT2A 458/4885GFER 3037/4885PRPS1 3878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback